
Matthew R. Lewin MD PhD
Director, Center for Exploration and Travel Health, California Academy of Sciences; Founder, Ophirex, Inc. A Public Benefit Corporation
Join to view full profile
5643 Paradise DriveCorte Madera, CA 94925
Phone+1 415-425-7892
Dr. Lewin is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Matthew Lewin is an emergency medicine physician in Corte Madera, CA. He received his medical degree from McGovern Medical School at UTHealth and has been in practice 18 years. He is experienced in travel and tropical medicine, general emergency medicine, wilderness medicine, expeditionary medicine, and exploration medicine. He has more than 60 publications and over 500 citations. Dr. Lewin is a recognized expert in expedition and field medicine, with emergency medicine board certification and a PhD in the field of neurophysiology. He is an elected fellow of the California Academy of Sciences, a fellow of the American College of Emergency Physicians, a National fellow of the Explorers Club, is currently President of the North American Society of Toxinology, and served on the WHO’s Snakebite Envenoming Working Group. He earned his MD and PhD at the University of Texas/MD Anderson Cancer Center Graduate School of Biomedical Sciences (Distinguished Alumnus award, 2020) and his BSc degree at the University of California, Berkeley.
Education & Training
University of California (San Francisco)/FresnoResidency, Emergency Medicine, 2001 - 2003
Zucker School of Medicine at Hofstra/NorthwellResidency, Emergency Medicine, 2000 - 2001
Sutter Health/California Pacific Medical CenterInternship, Internal Medicine, 1999 - 2000
McGovern Medical School at UTHealthClass of 1999
Certifications & Licensure
CA State Medical License 2000 - 2028
NY State Medical License 2010 - 2014
American Board of Emergency Medicine Emergency Medicine
Awards, Honors, & Recognition
- Fellow, California Academy of Sciences California Academy of Sciences, 2010
Publications & Presentations
PubMed
- Comparison of the efficacy of varespladib and coral snake antivenom against the activities of the Amazon coral snake (Micrurus spixii) venom.Nathalia M Cantuaria, Fernanda R Passos, Caroline Serino-Silva, Marisa M T da Rocha, Benedito Carlos Prezoto
Toxicon. 2026-10-01 - 4 citationsElectrical Cell Impedance Sensing (ECIS): Feasibility of a Novel In Vitro Approach to Studying Venom Toxicity and Potential Therapeutics.Abhinandan Choudhury, Kaitlin Linne, Tommaso C Bulfone, Tanvir Hossain, Abu Ali Ibn Sina
Toxins. 2025-04-11 - Corrigendum to "In vitro anticoagulant effects of Bungarus venoms on human plasma which are effectively neutralized by the PLA2-inhibitor varespladib" [Toxicon Volume ...Abhinandan Chowdhury, Bryan G Fry, Stephen P Samuel, Ashish Bhalla, Sakthivel Vaiyapuri
Toxicon. 2025-01-01
Press Mentions
Ophirex Receives Wellcome Trust Award to AdvanceMarch 2nd, 2020
Ophirex Licenses Lilly - Shionogi Data for Novel Snakebite Treatment Development ProgramAugust 28th, 2017
Trick of the Trade Epistaxis Control with Tongue BladesJanuary 29th, 2016
Grant Support
- Development of Intravenous Varespladib, a Phospholipase A2 Inhibitor, for the Treatment of Snakebite EnvenomingOPHIREX, INC.2023–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: